Effectiveness of Measles, Mumps and Rubella Vaccine in Health Care Professionals for COVID-19

Phase 3

• Conditions: COVID-19; Respiratory

• Registration Number: PACTR202006883882711
• Lead Sponsor: Dar Al Fouad Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-30
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

?Age 18-80 years old

?Subjects who are willing to comply with the requirements of the study protocol and scheduled visits (for example, completion of the subject diary, return for follow-up visits) and who are willing to make themselves available for the duration of the study with access to a consistent means of telephone contact,

Exclusion Criteria

?Acute severe illness
?Recent receipt of a blood product
?History of thrombocytopenia
?Pregnant females
?Any chronic medical condition
?Any participant receiving any immune suppressive medication
?Immunocompromised staff
?Participants who have egg allergy
?Participants who care for immune compromised hosts at home
?Participants who had documented COVID-19 either by RT-PCR or radiologically in the past six months

Study & Design

• Study Type: Interventional
• Study Design: Not specified